Medicaid Gives New Protections to Beneficiaries in Managed Care Plans

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 8
Volume 11
Issue 8

WASHINGTON-Final regulations issued by the Department of Health and Human Services guarantee Medicaid beneficiaries enrolled in managed care plans the same protections granted to people in private plans under legislation pending

WASHINGTON—Final regulations issued by the Department of Health and Human Services guarantee Medicaid beneficiaries enrolled in managed care plans the same protections granted to people in private plans under legislation pending in Congress. The regulations take effect Aug. 13, and states and health plans have 1 year to come into full compliance. 

The rules guarantee emergency room care, a second opinion when needed, and a timely right to appeal decisions. However, each state will decide how to implement patient protection and use managed care in its Medicaid plan.

Recent Videos
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 67th Annual ASH Meeting in Orlando.
4 experts are featured in this series.
Based on a patient’s SCLC subtype, and Schlafen 11 status, patients will be randomly assigned to receive durvalumab alone or with a targeted therapy in the S2409 PRISM trial.
4 experts are featured in this series.
Daniel Peters, MD, aims to reduce the toxicity associated with AML treatments while also improving therapeutic outcomes.
Numerous clinical trials vindicating the addition of immunotherapy to first-line chemotherapy in SCLC have emerged over the last several years.
Patients with AML will experience different toxicities based on the treatment they receive, whether it is intensive chemotherapy or targeted therapy.
A younger patient with AML who is more fit may be eligible for different treatments than an older patient with chronic medical conditions.
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Related Content